- Home
- GOVX vs SOHO Comparison
GOVX vs SOHO Comparison
Compare GOVX & SOHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- SOHO
- Stock Information
- Founded
- GOVX 2001
- SOHO 2004
- Country
- GOVX United States
- SOHO United States
- Employees
- GOVX N/A
- SOHO N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- SOHO Real Estate Investment Trusts
- Sector
- GOVX Health Care
- SOHO Real Estate
- Exchange
- GOVX Nasdaq
- SOHO Nasdaq
- Market Cap
- GOVX 16.8M
- SOHO 18.0M
- IPO Year
- GOVX N/A
- SOHO 2004
- Fundamental
- Price
- GOVX $0.60
- SOHO $0.91
- Analyst Decision
- GOVX Strong Buy
- SOHO
- Analyst Count
- GOVX 3
- SOHO 0
- Target Price
- GOVX $10.67
- SOHO N/A
- AVG Volume (30 Days)
- GOVX 1.2M
- SOHO 334.9K
- Earning Date
- GOVX 11-11-2025
- SOHO 11-13-2025
- Dividend Yield
- GOVX N/A
- SOHO N/A
- EPS Growth
- GOVX N/A
- SOHO N/A
- EPS
- GOVX N/A
- SOHO N/A
- Revenue
- GOVX $6,143,044.00
- SOHO $180,257,976.00
- Revenue This Year
- GOVX N/A
- SOHO $13.93
- Revenue Next Year
- GOVX N/A
- SOHO N/A
- P/E Ratio
- GOVX N/A
- SOHO N/A
- Revenue Growth
- GOVX 1943.07
- SOHO 1.07
- 52 Week Low
- GOVX $0.43
- SOHO $0.59
- 52 Week High
- GOVX $3.88
- SOHO $1.54
- Technical
- Relative Strength Index (RSI)
- GOVX 47.47
- SOHO 60.59
- Support Level
- GOVX $0.52
- SOHO $0.79
- Resistance Level
- GOVX $0.62
- SOHO $0.96
- Average True Range (ATR)
- GOVX 0.05
- SOHO 0.04
- MACD
- GOVX 0.01
- SOHO 0.01
- Stochastic Oscillator
- GOVX 71.36
- SOHO 78.64
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About SOHO Sotherly Hotels Inc.
Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.